People report experiencing value from learning genomic results even in the absence of clinically actionable information. Such personal utility has emerged as a key concept in genomic medicine. The lack of a validated patient-reported outcome measure of personal utility has impeded the ability to assess this concept among those receiving genomic results and evaluate the patient-perceived value of genomics. We aimed to construct and psychometrically evaluate a scale to measure personal utility of genomic results—the Personal Utility (PrU) scale.
We used an evidence-based, operational definition of personal utility, with data from a systematic literature review and Delphi survey to build a novel scale. After piloting with 24 adults, the PrU was administered to healthy adults in a Clinical Sequencing Evidence-Generating Research Consortium study after receiving results. We investigated the responses using exploratory factor analysis.
The exploratory factor analysis (N = 841 participants) resulted in a 3-factor solution, accounting for 74% of the variance in items: (1) self-knowledge (α = 0.92), (2) reproductive planning (α = 0.89), and (3) practical benefits (α = 0.91).
Our findings support the use of the 3-factor PrU to assess personal utility of genomic results. Validation of the PrU in other samples will be important for more wide-spread application.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
ACMG Member LoginAre you an ACMG Member? Sign in for online access.
Subscribe:Subscribe to Genetics in Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- What is clinical utility and why should we care?.Clin Pharmacol Ther. 2010; 88: 729-733https://doi.org/10.1038/clpt.2010.229
- Clinical utility. NCI Dictionaries.https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/clinical-utilityDate accessed: May 3, 2022
- What is the clinical utility of genetic testing?.Genet Med. 2006; 8: 448-450https://doi.org/10.1097/01.gim.0000227935.26763.c6
- Establishing the medical actionability of genomic variants.Annu Rev Genomics Hum Genet. 2022; 23: 173-192https://doi.org/10.1146/annurev-genom-111021-032401
- Clinical utility of genomic sequencing: a measurement toolkit.NPJ Genom Med. 2020; 5: 56https://doi.org/10.1038/s41525-020-00164-7
- Next-generation sequencing for clinical diagnostics.N Engl J Med. 2013; 369: 1557-1558https://doi.org/10.1056/NEJMe1310846
- Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time.Genet Med. 2011; 13: 499-504https://doi.org/10.1097/GIM.0b013e318220aaba
- Communication challenges for nongeneticist physicians relaying clinical genomic results.Per Med. 2016; 14: 423-431https://doi.org/10.2217/pme-2017-0008
- Personal utility in genomic testing: a systematic literature review.Eur J Hum Genet. 2017; 25: 662-668https://doi.org/10.1038/ejhg.2017.10
- Conceptualization of utility in translational clinical genomics research.Am J Hum Genet. 2021; 108: 2027-2036https://doi.org/10.1016/j.ajhg.2021.08.013
- Defining personal utility in genomics: a Delphi study.Clin Genet. 2017; 92: 290-297https://doi.org/10.1111/cge.12998
- Equity in genomic medicine.Annu Rev Genomics Hum Genet. 2022; 23: 613-625https://doi.org/10.1146/annurev-genom-112921-022635
- The Clinician-reported Genetic testing Utility InDEx (C-GUIDE): preliminary evidence of validity and reliability.Genet Med. 2022; 24: 430-438https://doi.org/10.1016/j.gim.2021.10.005
- The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine.Trials. 2014; 15: 85https://doi.org/10.1186/1745-6215-15-85
- Knowledge, motivations, expectations, and traits of an African, African-American, and Afro-Caribbean sequencing cohort and comparisons to the original ClinSeq® cohort.Genet Med. 2019; 21: 1355-1362https://doi.org/10.1038/s41436-018-0341-9
- Lessons learned about harmonizing survey measures for the CSER consortium.J Clin Transl Sci. 2020; 4: 537-546https://doi.org/10.1017/cts.2020.41
- Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access.Genet Med. 2022; 24: 1196-1205https://doi.org/10.1016/j.gim.2022.02.006
- The ACMG SF v3. 0 gene list increases returnable variant detection by 22% when compared with v2. 0 in the ClinSeq cohort.Genet Med. 2022; 24: 736-743https://doi.org/10.1016/j.gim.2021.11.012
- The Feelings About genomiC Testing Results (FACToR) Questionnaire: development and preliminary validation.J Genet Couns. 2019; 28: 477-490https://doi.org/10.1007/s10897-018-0286-9
- Educ Psychol Meas. 1974; 34: 111-117
Pett MA, Lackey NR, Sullivan JJ. Making Sense of Factor Analysis: The Use of Factor Analysis for Instrument Development in Health Care Research. SAGE Publishing, Inc; 2003.
- Multiple imputation: a primer.Stat Methods Med Res. 1999; 8: 3-15https://doi.org/10.1177/096228029900800102
- Bridging the gaps in personalized medicine value assessment: a review of the need for outcome metrics across stakeholders and scientific disciplines.Public Health Genomics. 2019; 22: 16-24https://doi.org/10.1159/000501974
- Utility of genetic testing from the perspective of parents/caregivers: a scoping review.Children (Basel). 2021; 8: 259https://doi.org/10.3390/children8040259
- Patient reported outcome measures: a model-based classification system for research and clinical practice.Qual Life Res. 2008; 17: 1125-1135https://doi.org/10.1007/s11136-008-9396-4
- Valuation of health and nonhealth outcomes from next-generation sequencing: approaches, challenges, and solutions.Value Health. 2018; 21 (Published correction appears in Value Health. 2019;22(4):502): 1043-1047https://doi.org/10.1016/j.jval.2018.06.010
- The opinions and experiences of people with intellectual disability regarding genetic testing and genetic medicine: a systematic review.Genet Med. 2022; 24: 535-548https://doi.org/10.1016/j.gim.2021.11.013
Published online: December 11, 2022
Accepted: December 7, 2022
Received in revised form: December 6, 2022
Received: September 13, 2022
Erin Turbitt and Jennefer N. Kohler are co–first authors.
© 2022 by American College of Medical Genetics and Genomics. Published by Elsevier Inc.